Kyntra Bio (KYNB) Retained Earnings (2014 - 2026)
Kyntra Bio (KYNB) posted Retained Earnings of -$1.9 million for Q1 2026, up 99.89% sequentially from -$1.7 billion in Q4 2025, and down 100.11% YoY from $1.7 billion in Q1 2025.
Kyntra Bio (KYNB) Retained Earnings (2014 - 2026) Analysis & Trends
Kyntra Bio has reported Retained Earnings for 13 years, with the latest figure at -$1.9 million in Q1 2026.
- Quarterly Retained Earnings fell 100.11% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 100.11% YoY) and the FY2025 annual result came in at -$1.7 billion, down 29663.56% from the prior year.
- Retained Earnings advanced to -$1.9 million in Q1 2026 per KYNB's latest filing, from -$1.7 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $1.7 billion in Q2 2025 and troughed at -$1.9 billion in Q3 2024.
- A 5-year average of -$60.8 million and a median of -$5.7 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings soared 234.89% in 2022, then tumbled 29663.56% in 2025.
- Over 5 years, Retained Earnings stood at -$5.7 million in 2022, then declined by 20.19% to -$6.9 million in 2023, then climbed by 16.63% to -$5.7 million in 2024, then sank by 29663.56% to -$1.7 billion in 2025, then surged by 99.89% to -$1.9 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$1.9 million, -$1.7 billion, and -$1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 4.38 Bn |
| 10 | Kyntra Bio | 29.96 Mn | 29.96 Mn | 1.47 Mn | -1.71 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.71 Bn |
| Mar 31, 2026 | -1.89 Mn |
| Dec 31, 2025 | -1.71 Bn |
| Sep 30, 2025 | -1.69 Bn |
| Jun 30, 2025 | 1.67 Bn |
| Mar 31, 2025 | 1.67 Bn |
| Dec 31, 2024 | -5.73 Mn |
| Sep 30, 2024 | -1.91 Bn |
| Jun 30, 2024 | 1.66 Bn |
| Mar 31, 2024 | -1.87 Bn |
| Dec 31, 2023 | -6.88 Mn |
| Sep 30, 2023 | -6.92 Mn |
| Jun 30, 2023 | -1.72 Bn |
| Mar 31, 2023 | -1.63 Bn |
| Dec 31, 2022 | -5.72 Mn |
| Sep 30, 2022 | 1.52 Bn |
| Jun 30, 2022 | 1.51 Bn |
| Mar 31, 2022 | 1.49 Bn |
| Dec 31, 2021 | -1.26 Bn |
| Sep 30, 2021 | -1.13 Bn |